Literature DB >> 26875877

L-Rhamnose isomerase and its use for biotechnological production of rare sugars.

Wei Xu1, Wenli Zhang1, Tao Zhang1, Bo Jiang1, Wanmeng Mu2,3.   

Abstract

L-Rhamnose isomerase (L-RI, EC 5.3.1.14), catalyzing the isomerization between L-rhamnose and L-rhamnulose, plays an important role in microbial L-rhamnose metabolism and thus occurs in a wide range of microorganisms. It attracts more and more attention because of its broad substrate specificity and its great potential in enzymatic production of various rare sugars. In this article, the enzymatic properties of various reported L-RIs were compared in detail, and their applications in the production of L-rhamnulose and various rare sugars including D-allose, D-gulose, L-lyxose, L-mannose, L-talose, and L-galactose were also reviewed.

Entities:  

Keywords:  D-Allose; L-Rhamnose isomerase; Monosaccharide; Rare sugar; Substrate specificity

Mesh:

Substances:

Year:  2016        PMID: 26875877     DOI: 10.1007/s00253-016-7369-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

Review 1.  Engineering ribose-5-phosphate isomerase B from a central carbon metabolic enzyme to a promising sugar biocatalyst.

Authors:  Hengtao Tang; Xin Ju; Jing Zhao; Liangzhi Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

2.  In silico functional annotation of hypothetical proteins from the Bacillus paralicheniformis strain Bac84 reveals proteins with biotechnological potentials and adaptational functions to extreme environments.

Authors:  Md Atikur Rahman; Uzma Habiba Heme; Md Anowar Khasru Parvez
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

3.  Genome-Wide Comparison Reveals a Probiotic Strain Lactococcus Lactis WFLU12 Isolated from the Gastrointestinal Tract of Olive Flounder (Paralichthys Olivaceus) Harboring Genes Supporting Probiotic Action.

Authors:  Thanh Luan Nguyen; Do-Hyung Kim
Journal:  Mar Drugs       Date:  2018-04-24       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.